Bio-Techne Corp (TECH)
Profitability ratios
Return on sales
| Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | |
|---|---|---|---|---|---|
| Gross profit margin | 66.39% | 67.70% | 69.13% | 69.01% | 33.14% |
| Operating profit margin | 17.83% | 26.29% | 27.10% | 25.88% | 10.80% |
| Pretax margin | 16.02% | 29.77% | 28.36% | 16.25% | 18.96% |
| Net profit margin | 14.50% | 25.09% | 24.86% | 15.31% | 15.72% |
Bio-Techne Corp's profitability ratios have shown some fluctuations over the past five years. The gross profit margin has been relatively stable, ranging from 33.14% in 2020 to 69.13% in 2022, indicating consistent control over production costs and pricing strategies. However, there was a slight decrease in the gross profit margin in 2024 compared to the previous years.
The operating profit margin has also varied, with a notable increase from 10.80% in 2020 to 27.10% in 2022, highlighting improving operational efficiency and cost management. However, there was a decrease in the operating profit margin in 2024, possibly indicating higher operating expenses relative to revenue.
The pretax margin fluctuated significantly, with a peak of 29.77% in 2023 and a drop to 16.02% in 2024. This suggests fluctuations in pre-tax earnings relative to total revenue, which may be influenced by factors such as tax expenses or non-operating income.
The net profit margin also showed variability, with a peak of 25.09% in 2023 and a decline to 14.50% in 2024. This measure reflects the company's profitability after accounting for all expenses, including taxes. The decrease in 2024 might indicate higher expenses impacting the bottom line.
Overall, the profitability ratios of Bio-Techne Corp exhibit a mix of trends, with some improvements in efficiency and profitability in certain years, but also fluctuations and potential challenges in maintaining consistent profitability levels. Further analysis of the company's financial performance and strategy would be needed to provide a comprehensive assessment.
Return on investment
| Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 7.64% | 11.33% | 12.92% | 10.49% | 7.76% |
| Return on assets (ROA) | 6.22% | 10.81% | 11.86% | 6.20% | 11.31% |
| Return on total capital | 9.99% | 17.78% | 18.90% | 10.43% | 21.41% |
| Return on equity (ROE) | 8.13% | 14.51% | 15.99% | 8.98% | 16.60% |
Bio-Techne Corp's profitability ratios show fluctuations over the past five years.
1. Operating return on assets (Operating ROA) has decreased progressively from 12.92% in 2022 to 7.64% in 2024. This indicates that the company's operating income generated from its assets has been declining.
2. Return on assets (ROA) demonstrates a mixed trend with fluctuations. While it was the highest at 11.86% in 2022, it dropped notably to 6.20% in 2021 before rebounding to 10.81% in 2023.
3. Return on total capital has also displayed variability, with significant decreases in 2021 and 2024. The ratio dropped to its lowest point in 2024 at 9.99%, indicating a decline in the company's overall efficiency in generating returns from its total capital.
4. Return on equity (ROE) follows a similar pattern to ROA, with fluctuations throughout the years. The highest value was recorded at 16.60% in 2020, followed by a decrease to 8.98% in 2021 and another decline to 8.13% in 2024.
In general, Bio-Techne Corp's profitability ratios suggest that the company has experienced some challenges in optimizing its profitability over the past five years. Further analysis of the company's financial performance and operational efficiency may be warranted to identify underlying factors contributing to these fluctuations.